Exhibit 10.28.3
REDACTED VERSION
[SERACARE LETTERHEAD]
*** Confidential treatment has been requested as to certain portions of
this agreement. Such omitted confidential information has been designated
by an asterisk and has been filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange
Act of 1934, as amended, and the Commission's rules and regulations
promulgated under the Freedom of Information Act, pursuant to a request
for confidential treatment.***
November 6, 2000
Sr. Xxxxx Xxxxx
Managing Director
Grifols International, X.X.
Xxxxx Maffre-Planta 26
C/de la marina
Xxxxxxxxx, Xxxxx 00000
Dear Xxxxx:
Sorry for the delay. I am committed to supplying Grifols with *** liters of
plasma in calendar year 2001 and I continue to believe that the current
plasma price for delivery in 2001 is US *** per liter (non-pcr tested);
however, I would like to propose the following:
Base Price per liter = US ***
30 day inventory hold
payment 30 days from date of shipment
Pricing adjustment: using a base Euro/Dollar exchange rate of .855, for every
5% improvement in the Euro against the dollar exchange rate the price would
increase by US $.50 adjusted quarterly.
If you have any questions, I will be in the office the rest of the week.
Best regards,
/s/ Xxxxx
----------------------
Xxxxx X. Xxxxx
Chief Executive Officer
BDP:ds
Cc: Xx. Xxxxxx Xxxxx
0000 Xxxxxxx Xxxx Xxxx, Xxxxx 0000, Xxx Xxxxxxx, XX 00000
-------------------------------
*** Confidential information omitted and filed separately with the Securities
and Exchange Commission.
